Identifying and managing adverse prognosis biomarkers among advanced luminal breast cancer patients: What have we learned? Cottu P. Eur J Cancer 2025 Jan 10:115228. doi: 10.1016/j.ejca.2025.115228.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cottu P. Identifying and managing adverse prognosis biomarkers among advanced luminal breast cancer patients: What have we learned? Eur J Cancer 2025 Jan 10:115228. doi: 10.1016/j.ejca.2025.115228.
PMID: 39809627